Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2025 Earnings Call Transcript May 6, 2025
Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.63, expectations were $0.14.
Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2025. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Ray Furey, Rigel’s Executive Vice President, General Counsel and...
